Table 3. Attitude towards ADR reporting practices among doctors in Addis Ababa, 2017 (n = 407).
| Variables | n(%) | ||||
|---|---|---|---|---|---|
| SA* | Agree | Undecided | Disagree | SD* | |
| ADR reporting is duty of health professionals | 142 (34.9) | 246 (60.4) | 12 (2.9) | 6 (1.5) | 1(0.2) |
| ADRs need to be sure before reporting | 109(26.8) | 272(66.8) | 22(5.4) | 4(1.0) | 0(0) |
| ADR report improves patient’s safety | 130(31.9) | 261(64.1) | 16(3.9) | 0(0) | 0(0) |
| All suspected ADRs should be reported | 68(16.7) | 195(47.9) | 52(12.8) | 83(20.4) | 9(2.2) |
| ADR reporting trends identify relatively safe drugs | 76(18.7) | 252(61.9) | 53(13.0) | 20(4.9) | 6(1.5) |
| ADR reporting creates workload | 4(1.0) | 51(12.5) | 63(15.5) | 211(51.8) | 78(19.2) |
| ADR reporting is not important for healthcare system | 2(0.5) | 14(3.4) | 29(7.1) | 229(56.3) | 133(32.7) |
| Reporting of ADR affects patient’s confidentiality issues | 5(1.2) | 30(7.4) | 136(33.4) | 179(44.0) | 57(14.0) |
| A single ADR report brings no difference | 3(0.7) | 42(10.3) | 77(18.9) | 170(41.8) | 115(28.3) |
| Fear of legal liability affects ADR reporting | 17(4.2) | 192(47.2) | 128(31.4) | 61(15.0) | 9(2.2) |
* SA represent as “strongly agree” and SD as “strongly disagree”